UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study

Critical care (London, England), 2019-09, Vol.23 (1), p.317-317, Article 317

2019

Volltextzugriff (PDF)

Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality

Hepatology (Baltimore, Md.), 2023-03, Vol.77 (3), p.942-948

2023

Volltextzugriff (PDF)

Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

Hepatology (Baltimore, Md.), 2015-05, Vol.61 (5), p.1512-1522

2015

Volltextzugriff (PDF)

ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection

PloS one, 2015-10, Vol.10 (10), p.e0139317-e0139317

2015

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2024-09

2024

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2024-09

2024

Volltextzugriff (PDF)

Search engine optimization for scientific publications: How one can find your needle in the haystack

United European gastroenterology journal, 2022-10, Vol.10 (8), p.906-908

2022

Volltextzugriff (PDF)

FRI-209 Differential prevalence and prognostic value of metabolic syndrome components among metabolic-dysfunction associated steatotic liver disease (MASLD) patients

Journal of hepatology, 2024-06, Vol.80, p.S467-S468

2024

Volltextzugriff (PDF)

SAT-453 Diagnostic accuracy of the LiverRisk score to detect significant and advanced fibrosis among a United States general population and important subgroups

Journal of hepatology, 2024-06, Vol.80, p.S649-S650

2024

Volltextzugriff (PDF)

SAT-437-YI MAF-5 improves the detection of advanced and significant fibrosis in FIB-4 underserved individuals in a United States general population

Journal of hepatology, 2024-06, Vol.80, p.S643-S643

2024

Volltextzugriff (PDF)

SAT-443 FIB-4 based referral pathways to identify advanced liver disease have poor clinical utility in a United States general population

Journal of hepatology, 2024-06, Vol.80, p.S646-S646

2024

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2024-09

2024

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2023-04, Vol.77 (4), p.E69-E70

2023

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2023-03, Vol.77 (3), p.E45-E46

2023

Volltextzugriff (PDF)

SAT-197-YI Higher serum vitamin D levels is associated with lower MASLD prevalence and incidence: the Rotterdam study

Journal of hepatology, 2024-06, Vol.80, p.S604-S605

2024

Volltextzugriff (PDF)

Treatment of diabetes mellitus in patients with chronic hepatitis B: Are SGLT2 inhibitors hitting the sweet spot?

Hepatology (Baltimore, Md.), 2023-11, Vol.78 (5), p.1334-1336

2023

Volltextzugriff (PDF)

Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis

Journal of hepatology, 2018-01, Vol.68 (1), p.92-99

2018

Volltextzugriff (PDF)

Hyperhomocysteinaemia and MASLD: Causal relationship or spurious correlation?

European journal of internal medicine, 2024-11

2024

Volltextzugriff (PDF)

SAT-200-YI Statin use is associated with liver fibrosis regression in the general population: a longitudinal analysis of The Rotterdam Study

Journal of hepatology, 2024-06, Vol.80, p.S606-S606

2024

Volltextzugriff (PDF)

Metabolic dysfunction-associated steatohepatitis reduces interferon and macrophage liver gene signatures in patients with chronic hepatitis B

Journal of hepatology, 2024-10

2024

Volltextzugriff (PDF)

FRI-200 Magnitude of steatotic liver disease before and after liver transplantation and the impact of immunosuppressive medication: a multidimensional study

Journal of hepatology, 2024-06, Vol.80, p.S464-S464

2024

Volltextzugriff (PDF)

SAT-462-YI The interplay between steototic liver disease and viral infections: systematic review, meta-analysis and data synthesis

Journal of hepatology, 2024-06, Vol.80, p.S652-S653

2024

Volltextzugriff (PDF)

Metabolic dysfunction associated fatty liver disease in healthy weight individuals

Hepatology international, 2024-10, Vol.18 (Suppl 2), p.884-896

2024

Volltextzugriff (PDF)

Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page?

Journal of hepatology, 2020-09, Vol.73 (3), p.728-729

2020

Volltextzugriff (PDF)

SAT428 - Early PEG-interferon-related ALT flares of high magnitude lead to HBsAg decline and loss. A study of 639 chronic hepatitis B patients

Journal of hepatology, 2020-08, Vol.73, p.S866-S866

2020

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(66)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study

Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality

Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection

Reply

Reply

Search engine optimization for scientific publications: How one can find your needle in the haystack

FRI-209 Differential prevalence and prognostic value of metabolic syndrome components among metabolic-dysfunction associated steatotic liver disease (MASLD) patients

SAT-453 Diagnostic accuracy of the LiverRisk score to detect significant and advanced fibrosis among a United States general population and important subgroups

SAT-437-YI MAF-5 improves the detection of advanced and significant fibrosis in FIB-4 underserved individuals in a United States general population

SAT-443 FIB-4 based referral pathways to identify advanced liver disease have poor clinical utility in a United States general population

Reply

Reply

Reply

SAT-197-YI Higher serum vitamin D levels is associated with lower MASLD prevalence and incidence: the Rotterdam study

Treatment of diabetes mellitus in patients with chronic hepatitis B: Are SGLT2 inhibitors hitting the sweet spot?

Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis

Hyperhomocysteinaemia and MASLD: Causal relationship or spurious correlation?

SAT-200-YI Statin use is associated with liver fibrosis regression in the general population: a longitudinal analysis of The Rotterdam Study

Metabolic dysfunction-associated steatohepatitis reduces interferon and macrophage liver gene signatures in patients with chronic hepatitis B

FRI-200 Magnitude of steatotic liver disease before and after liver transplantation and the impact of immunosuppressive medication: a multidimensional study

SAT-462-YI The interplay between steototic liver disease and viral infections: systematic review, meta-analysis and data synthesis

Metabolic dysfunction associated fatty liver disease in healthy weight individuals

Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page?

SAT428 - Early PEG-interferon-related ALT flares of high magnitude lead to HBsAg decline and loss. A study of 639 chronic hepatitis B patients

Suchergebnisse filtern